Aluminum alters the permeability of the blood-brain barrier to some non-peptides
- PMID: 4022265
- DOI: 10.1016/0028-3908(85)90025-5
Aluminum alters the permeability of the blood-brain barrier to some non-peptides
Abstract
The effect of aluminum administered intraperitoneally (i.p.) on the levels of peripherally injected 99mTc labelled red blood cells in brain and on the penetration of the blood-brain barrier by radioiodinated serum albumin (RISA), thyroxine, iodide, cortisol, N-Tyr-delta sleep-inducing peptide (N-Tyr-DSIP), growth hormone, thyroid stimulating hormone (TSH), prolactin and human and rat luteinizing hormone was examined. Treatment with aluminum did not alter the brain/blood ratio for either 99mTc red blood cells or RISA, although it did increase the blood levels of RISA. These results show that aluminum caused a contraction in the volume of plasma without altering the vascular space of the brain, disrupting the blood-brain barrier, or increasing the "leakiness" of the blood-brain barrier. Aluminum enhanced the permeability of the blood-brain barrier to labelled prolactin, thyroxine, cortisol, growth hormone, N-Tyr-DSIP and rat luteinizing hormone, but not to labelled TSH, iodide, or human luteinizing hormone, a substance with an octanol coefficient markedly different from that of luteinizing hormone from the rat. Incubation of the peptide with aluminum before injection did not increase penetration, demonstrating that aluminum did not increase the permeability of the blood-brain barrier by acting directly on the peptide. Aluminum, administered intraperitoneally, increased the accuracy of lipophilicity as a predictor of penetration of the blood-brain barrier, but the greatest increase in penetration was seen with thyroxine, a substance which crosses the blood-brain barrier by carrier-mediated transport.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
The aluminum-induced increase in blood-brain barrier permeability to delta-sleep-inducing peptide occurs throughout the brain and is independent of phosphorus and acetylcholinesterase levels.Psychopharmacology (Berl). 1985;86(1-2):84-9. doi: 10.1007/BF00431689. Psychopharmacology (Berl). 1985. PMID: 3927370
-
Differential penetration of DSIP peptides into rat brain.Pharmacol Biochem Behav. 1982 Dec;17(6):1187-91. doi: 10.1016/0091-3057(82)90118-6. Pharmacol Biochem Behav. 1982. PMID: 6897680
-
Modulation of immunoactive levels of DSIP and blood-brain permeability by lighting and diurnal rhythm.J Neurosci Res. 1985;14(3):347-55. doi: 10.1002/jnr.490140307. J Neurosci Res. 1985. PMID: 3840534
-
Congenital Hypopituitarism.Clin Perinatol. 2018 Mar;45(1):75-91. doi: 10.1016/j.clp.2017.11.001. Clin Perinatol. 2018. PMID: 29406008 Review.
-
Aluminum-induced neurotoxicity: alterations in membrane function at the blood-brain barrier.Neurosci Biobehav Rev. 1989 Spring;13(1):47-53. doi: 10.1016/s0149-7634(89)80051-x. Neurosci Biobehav Rev. 1989. PMID: 2671833 Review.
Cited by
-
Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier.Pharm Res. 1995 Oct;12(10):1395-406. doi: 10.1023/a:1016254514167. Pharm Res. 1995. PMID: 8584471 Review.
-
Potential Role of Fluoride in the Etiopathogenesis of Alzheimer's Disease.Int J Mol Sci. 2018 Dec 9;19(12):3965. doi: 10.3390/ijms19123965. Int J Mol Sci. 2018. PMID: 30544885 Free PMC article. Review.
-
Effect of the aluminium ion on hepatic elimination of quinine and quinidine.Eur J Drug Metab Pharmacokinet. 1995 Jul-Sep;20(3):185-90. doi: 10.1007/BF03189668. Eur J Drug Metab Pharmacokinet. 1995. PMID: 8751039
-
Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.Environ Geochem Health. 1990 Mar;12(1-2):103-14. doi: 10.1007/BF01734059. Environ Geochem Health. 1990. PMID: 24202576
-
Peptides at the blood brain barrier: Knowing me knowing you.Peptides. 2015 Oct;72:50-6. doi: 10.1016/j.peptides.2015.04.020. Epub 2015 Apr 30. Peptides. 2015. PMID: 25937599 Free PMC article. Review.